Miura, Kumi Watanabe
Sekiguchi, Takuya
Tokunaga, Seiki
Sugimoto, Hikaru
Kishimoto, Taishiro
Kudo, Takashi
Otake-Matsuura, Mihoko
Funding for this research was provided by:
Japan Society for the Promotion of Science (21J01494, JP22H04872)
Japan Science and Technology Agency (JPMJCR20G1)
Article History
Received: 15 February 2025
Accepted: 3 September 2025
First Online: 14 October 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. The trial was registered with the University Hospital Medical Information Network (UMIN) clinical trials registry (UMIN000047247) and approved by the RIKEN ethics committee (RIKEN-W3-2021-049). Informed consent was obtained from all participants. All data were anonymized before analysis to ensure participant confidentiality. Participants in both groups received equal cash compensation of 15,000 JPY. If additional time was required (e.g., for intervention evaluation), an extra 1,000 JPY per hour was provided.
: Not applicable.
: The authors declare no competing interests.